mRNA nanomedicine: Design and recent applications

Area of Science:

• Biotechnology
• Nanomedicine
• Molecular Biology

Background:

• Messenger RNA (mRNA) medicine enables direct in vivo protein production, improving upon traditional biological therapies.
• mRNA technology offers faster development cycles and simpler production compared to conventional methods.
• Despite advantages, mRNA's fragility and specific delivery needs necessitate advanced formulation strategies.

Purpose of the Study:

• To review the design principles of mRNA-based nanomedicine platforms.
• To detail current research on mRNA nanoformulations for various diseases.
• To explore the future potential of mRNA nanomedicine in clinical applications.

Main Methods:

• Engineering mRNA payloads into nanoformulations using nanobiotechnology.
• Designing formulations to avoid immune responses and target specific tissues.
• Ensuring cytosolic delivery of mRNA for enhanced bioactivity and safety.

Main Results:

• Nanoformulations improve mRNA safety and bioactivity by controlling immune responses and targeting delivery.
• Current research focuses on mRNA nanoformulations for viral infections, cancers, and genetic diseases.
• Novel nanomedicine technologies are poised to enhance the clinical utility of mRNA therapeutics.

Conclusions:

• mRNA nanomedicine leverages nanobiotechnology to overcome mRNA's inherent limitations.
• Advanced mRNA nanoformulations show promise for treating a range of human diseases.
• Future developments in mRNA-based nanomedicine could revolutionize clinical disease management.